Spinal Cord Regeneration: Scar-degrading Enzyme Nov 5, 2009
This research was funded by Award No. R01 NS043486 from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH). The content is solely the responsibility of the principal investigator and does not necessarily represent the official view of the NINDS or the NIH.. (Science Daily)
Clinical Tests Begin On Medication To Correct Fragile X Defect Nov 4, 2009
The National Institute of Mental Health, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Institute of Neurological Disorders and Stroke (NINDS) have provided grant support. Private foundations providing funding include the advocacy groups Autism Speaks and FRAXA Research Foundation. (Science Daily)
Investment in Parkinson's disease data bank yields potential therapy Oct 13, 2009
Investigators demonstrated the link with urate by mining a repository of clinical data and tissue samples collected from Parkinson's patients more than 20 years ago as part of a pioneering study called DATATOP, funded by NIH's National Institute of Neurological Disorders and Stroke (NINDS) ... It was funded primarily by NINDS, with additional support from the Department of Defense and private organizations ... D., a program director at NINDS.. (EurekAlert!)
Travolta Admits Late Son Had Autism Sep 25, 2009
In Extortion Trial Testimony, Star and Scientologist Says For First Time Son Had Illness, and Had Seizures Regularly. John Travolta took the stand in an extortion trial surrounding the death of his son, who the actor admitted was Autistic. (CBS News)
High Blood Pressure Linked To Memory Problems In Middle Age Aug 27, 2009
The study was supported by the National Institute of Neurological Disorders and Stroke (NINDS). "The REGARDS study is one of the largest population-based studies of risk factors for stroke. These latest data suggest that higher blood pressure may be a risk factor for cognitive decline, but further studies will be necessary to understand the cause-effect relationship," said Walter J. Koroshetz, MD, deputy director of NINDS and Fellow of the American Academy of Neurology. (Science Daily)
Key Factor That Stimulates Brain Cancer Cells To Spread Identified Aug 21, 2009
D., a program director at NIH's National Institute of Neurological Disorders and Stroke (NINDS). NINDS funded the new study through an initiative that encourages research on why brain tumor cells are so highly invasive and how to therapeutically target these cells. (Science Daily)
Mighty Mice: Treatment Targeted To Muscle Improves Motor Neuron Disease Aug 15, 2009
The researchers include Isabella Palazzolo, NINDS, NIH, Bethesda, MD, Universitadegli Studi di Milano, Milan; Conor Stack, NINDS, NIH, Bethesda, MD; Lingling Kong, Johns Hopkins School of Medicine, Baltimore, MD; Antonio Musaro, Sapienza University of Rome, Italy; Hiroaki Adachi, Nagoya University Graduate School of Medicine, Nagoya, Japan; Masahisa Katsuno, Nagoya University Graduate School of Medicine, Nagoya, Japan, Nagoya University, Nagoya, Japan; Gen Sobue, Nagoya University Graduate... (Science Daily)
GEORGE B. KAUFFMAN: Alzheimer's: The plague of baby boomers? Aug 15, 2009
3 million grant award from the National Institute of Neurological Disorders and Stroke (NINDS) for development of a vaccine for Alzheimers disease. Ichor is collaborating on the project with Dr. Michael Agadjanyan, Vice President and Head of Immunology at the Institute for Molecular Medicine (IMM), Huntington Beach, CA; Dr. David H. Cribbs, Professor, Department of Neurology and Institute for Memory Impairments and Neurological Disorders at the University of California, Irvine (UCI); and Dr.... (Fresno Bee -- Opinion)
Coriell Institute wins $16M NIH contract Aug 15, 2009
The NINDS international repository project will have the goal of improving human health by accelerating the discovery of genetic risk factors for neurological disease a process that requires specimens and clinical data from thousands of individuals. Reader Comments. (Philadelphia Business Journal, PA)
From Nerve Roots To Plant Roots: Research On Hereditary Spastic Paraplegia Yields Surprises Aug 10, 2009
D., an investigator at NIH's National Institute of Neurological Disorders and Stroke (NINDS) and an HSP expert. Dr. Blackstone performed the study in collaboration with William Prinz, Ph. (Science Daily)
Novel Drug Discovery Tool Could Identify Promising New Therapies For Parkinson's Disease Jul 18, 2009
D., a program director at NIH's National Institute of Neurological Disorders and Stroke (NINDS) ... Dr. Lindquist is also an investigator at the Massachusetts General Hospital (MGH)/MIT Morris K. Udall Center for Excellence in Parkinson's Research, one of 14 such centers funded by NINDS to develop treatment breakthroughs for Parkinson's disease ... NINDS is currently supporting clinical trials in patients to test whether specific antioxidants slow the progression of Parkinson's disease. (Science Daily)
Narcolepsy is an Autoimmune Disorde... Jul 6, 2009
In the Stanford study, which was funding by the National Institute of Healths s Dividsion of Neurological Disorders and Storkes (NINDS) researchers set out to find what immune system influences contribute to narcolepsy. Understanding Narcolepsy. (Suite101.com)
Man, 100, to finally meet sick great-grandaughter Jun 22, 2009
Updated Sunday, June 21, 2009. Weather Sponsored By. (Lompoc Record, CA)
Families of Spinal Muscular Atrophy Announces Latest Developments on Three SMA Drug Discovery Programs Jun 19, 2009
D., Director, Inflammation Drug Discovery, Paratek Pharmaceuticals, "FSMA has supported the research at Paratek for the previous three years for our work on tetracycline derivatives as a potential treatment of SMA. These compounds are intended to correct SMN2 splicing and in turn increase SMN protein levels. Using funding from FSMA to generate the preliminary data for a grant application, Paratek has been awarded a multi-million dollar U01 grant from the NINDS to continue our research that FSMA... (PR Newswire)
Common autism medication is ineffective for repetitive behaviors, study finds Jun 2, 2009
The research was funded by the Studies to Advance Autism Research and Treatment (STAART) network which is jointly funded by: NIMH, the National Institute of Neurological Disorders and Stroke (NINDS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute on Deafness and Other Communication Disorders, and the National Institute of Environmental Health Sciences, all part of the NIH.. King's research partners participating in the study included:... (EurekAlert!)
Citalopram no better than placebo treatment for children with autism spectrum disorders Jun 2, 2009
D., Boston University; Deborah Hirtz, M.D., National Institute of Neurological Disorders and Stroke (NINDS); Ann Wagner, Ph. D., NIMH; Louise Ritz, M.B.A., NIMH (currently at NINDS); and the STAART Psychopharmacology Network ... The STAART network is jointly funded by NIMH, NINDS, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute on Deafness and Other Communication Disorders (NIDCD), and the National Institute of Environmental... (EurekAlert!)
Antidepressant ineffective against autism spectrum disorder children's obsessive behavior Jun 2, 2009
The authors on the paper included: Bryan H. King, MD, Seattle Children's Hospital; Eric Hollander, MD, Mount Sinai School of Medicine; Linmarie Sikich, MD, University of North Carolina, Chapel Hill; James T. McCracken, MD, University of California Los Angeles; Lawrence Scahill, MSN., PhD, Yale University; Dr. Bregman, MD, of the Feinstein Institute and North Shore Long Island Jewish Health System; Craig L. Donnelly, MD, Dartmouth Medical School; Evdokia Anagnostou, MD, Mount Sinai School of... (EurekAlert!)
Novel Spinal Cord Stimulator Sparks Hope For Parkinson's Disease Treatment Mar 22, 2009
Funding for this research was provided by grants from the National Institutes of Neurological Disorders and Stroke (NINDS), International Neuroscience Network Foundation (INNF) and the Anne W. Deane Endowed Chair. Adapted from materials provided by. (Science Daily)
Experts dispute Lyme disease-violence claim Mar 10, 2009
Past Month's Most Commented Stories. Monday, March 9, 2009 3:45 PM PDT. (Longview Daily News, WA)
Could Genetics Improve Warfarin Dosing? New Research Says Yes -- Now For The Clinical Trial Feb 20, 2009
In addition to NIGMS, the following NIH components supported the consortium's research: the National Heart, Lung, and Blood Institute (NHLBI), the National Institute of Neurological Disorders and Stroke (NINDS), and the National Center for Research Resources (NCRR). Moving from the Computer to the Clinic. (Science Daily)
